Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. - Woyach, Jennifer; Tedeschi, Alessandra; Munir, Talha; Siddiqi, Tanya; Hillmen, Peter; Byrd, John C.; Ghia, Paolo; Mulligan, Stephen P.; Dai, Sandra; Amaya-Chanaga, Carlos I.; Dean, James P.; O'Brien, Susan M.; et al. (Leukemia & Lymphoma, 2021)